Natural alternatives to Ozempic: Evidence-based strategies for GLP-1 enhancement and weight loss

The meteoric rise of semaglutide drugs like Ozempic and Wegovy has revolutionized weight loss treatment, but their high cost and limited availability have many seeking natural alternatives. While nature’s pharmacy can’t fully replicate these powerful medications, emerging research reveals promising strategies that harness your body’s own GLP-1 system. Understanding both the science and realistic expectations helps create an effective, sustainable approach to weight management.

How semaglutide drugs revolutionized weight loss

Semaglutide belongs to a class of medications called GLP-1 receptor agonists, which mimic a naturally occurring hormone produced in your intestines. When you eat, specialized cells release GLP-1 (glucagon-like peptide-1), triggering a cascade of effects: your brain receives fullness signals, your stomach empties more slowly, and your pancreas releases insulin more effectively. The problem? Natural GLP-1 breaks down within minutes.

Semaglutide’s genius lies in its molecular modification. Scientists engineered it to resist breakdown, extending its action from mere minutes to over 46 hours. This sustained activity produces multiple weight-loss effects, including potent appetite suppression via brain pathways that regulate hunger and food reward, delayed gastric emptying that prolongs feelings of fullness, and improved blood sugar control. Clinical trials have shown an average weight loss of 15-16% with semaglutide over 68 weeks, with some newer medications achieving even greater results.

Nutrients and supplements that naturally enhance GLP-1

While no supplement matches semaglutide’s potency, several compounds can stimulate your body’s natural GLP-1 production. The most promising include specific types of fiber, amino acids, and plant compounds that work through different mechanisms:

• Resistant starch leads the pack as nature’s GLP-1 booster. Found in cooked and cooled potatoes, green bananas, and oats, this fiber ferments in your colon, producing short-chain fatty acids that directly stimulate GLP-1-releasing cells. Studies show that resistant starch increases both GLP-1 and PYY (another satiety hormone), although the effects remain modest compared to medications. Aim for 15-20 grams daily, gradually increasing to avoid digestive discomfort.
• Beta-glucans, the soluble fiber in oats and barley, demonstrate powerful GLP-1-stimulating effects. Research indicates that beta-glucan induced the most weight loss among fiber types in animal studies, likely through sustained fermentation and direct stimulation of intestinal cells. A daily bowl of steel-cut oats provides approximately 4 grams of beta-glucan, offering additional cardiovascular benefits.
• Berberine, a compound from goldenseal and barberry, shows the most clinical promise among herbal supplements. Meta-analyses reveal an average weight loss of 4.5 pounds over several months, with daily doses of 1,000-1,500 mg. Berberine activates AMPK (often called the body’s “metabolic master switch”) and stimulates GLP-1 through bitter taste receptors in the gut. However, it interacts with numerous medications and requires medical supervision.
• Plant-based proteins provide GLP-1 stimulation through their amino acid profiles. Studies show consuming 20-30 grams of pea, hemp, or soy protein before meals can enhance GLP-1 and insulin release. The effect lasts 2-4 hours, which is far shorter than that of semaglutide, but it is still helpful for meal management. Key amino acids like phenylalanine and arginine, abundant in legumes and seeds, appear most effective for GLP-1 stimulation.
• Akkermansia muciniphila is a beneficial gut bacterium comprising 3-5% of a healthy microbiome. This microbe produces a protein that directly stimulates GLP-1 secretion while strengthening gut barrier function. While Akkermansia supplements exist, supporting overall microbiome health through diverse fiber intake may prove more beneficial.

Dietary strategies that support natural GLP-1 production

The Mediterranean diet emerges as the gold standard for natural GLP-1 enhancement. Research demonstrates that this eating pattern, rich in olive oil, vegetables, legumes, and whole grains, produces significantly higher post-meal GLP-1 levels compared to typical Western diets. The combination of monounsaturated fats, fiber, and polyphenols creates synergistic effects on GLP-1 secretion.

The beans, greens, and nuts/seeds trifecta

One of the most practical applications of GLP-1-friendly eating centers on three food groups that stimulate GLP-1 through entirely different mechanisms: beans, leafy greens, and nuts or seeds. When combined in a single meal, their effects are additive. The synergy comes from fiber fermentation, healthy fats activating fatty-acid receptors, and slow-digesting plant protein, creating a multi-pathway approach that mirrors the GLP-1-enhancing pattern observed in Mediterranean diet studies.

• Beans and legumes are among the most reliable whole-food GLP-1 boosters available. They are rich in soluble, fermentable fiber, which gut bacteria convert into short-chain fatty acids (SCFAs). These SCFAs activate FFAR2 and FFAR3 receptors on L-cells, the specialized intestinal cells that produce GLP-1, directly triggering its release. Human studies confirm that fermentable fiber increases GLP-1 secretion after meals. Beans also slow gastric emptying, which prolongs GLP-1’s satiety effect and gives the hormone more time to act on appetite-regulating centers in the brain.
• Leafy greens such as kale, collards, spinach, mustard greens, and broccoli leaves provide a moderate GLP-1 stimulus through a different mechanism. Their combination of insoluble and soluble fiber slows digestion and enhances distal gut nutrient delivery, which matters because L-cells are most concentrated in the lower portions of the small intestine and colon. Greens also contain nitrates and polyphenols that may indirectly support GLP-1 signaling by favorably shifting the microbiome. On their own, leafy greens are a mild GLP-1 stimulant, but they meaningfully amplify the effect of beans by ensuring nutrients reach the gut regions where GLP-1 production is highest.
• Nuts and seeds add a fat-mediated boost that complements the fiber-mediated pathway. Their mono- and polyunsaturated fats activate free fatty acid receptors FFAR1 and FFAR4 on L-cells, directly stimulating GLP-1 secretion through an entirely separate signaling cascade. Nuts also slow gastric emptying and blunt postprandial glucose spikes, which indirectly supports sustained GLP-1 activity.

The reason this combination outperforms any one food group alone comes down to anatomy and receptor diversity. GLP-1 is released most strongly when nutrients reach the distal small intestine and colon, where L-cells are densely concentrated. Beans provide the strongest individual stimulus by generating SCFAs that activate FFAR2 and FFAR3 in the colon. Greens slow transit, allowing more nutrients to reach the lower gut, amplifying the bean effect even though their direct GLP-1 contribution is moderate. Nuts and seeds activate FFAR1 and FFAR4, an entirely separate receptor family, layering a fat-mediated signal on top of the fiber-mediated one. When all three food groups are consumed in the same meal, the gut experiences prolonged nutrient sensing across multiple receptor pathways simultaneously, producing a combined GLP-1 response that exceeds what any single food group delivers on its own.

A practical high-GLP-1 meal that activates all three pathways might include black beans or lentils as the base, steamed kale or collards, a handful of walnuts or pumpkin seeds, and a drizzle of olive oil with lemon. Adding quinoa or barley provides resistant starch, which supports additional SCFA production. This type of bowl maximizes SCFA generation, fat-receptor activation, slow gastric emptying, and distal gut nutrient delivery in a single sitting.

Protein prioritization

Protein prioritization is crucial, with studies showing that an optimal GLP-1 response occurs at 1.2 grams per kilogram of body weight daily (approximately 0.55 grams per pound). Distributing protein across meals, aiming for 25–30 grams per meal, maintains steady GLP-1 stimulation. Plant-based proteins, combined with healthy fats, may offer additional benefits over animal proteins alone.

Meal sequencing

Meal sequencing offers a simple yet effective strategy. Research reveals that consuming vegetables before carbohydrates significantly increases GLP-1 levels, particularly 60 minutes after the meal. This “food order” approach costs nothing and requires only mindful planning. Similarly, consuming meals over 30 minutes rather than 5 minutes yields measurably higher GLP-1 responses.

Time-restricted eating

Time-restricted eating shows promise for enhancing the effectiveness of GLP-1. The popular 16:8 method (16-hour fast, 8-hour eating window) may improve the body’s sensitivity to natural GLP-1. Studies demonstrate that more extended fasting periods, combined with structured eating windows, can enhance weight loss. One trial showed 8.5% weight loss with a 14:10 timing regimen versus 7.1% with a 12:12 regimen.

Fermented foods

Fermented foods deserve special attention for their dual action: providing beneficial bacteria and producing metabolites that stimulate GLP-1 release. Regular consumption of yogurt, kefir, sauerkraut, and kimchi supports the gut microbes that produce short-chain fatty acids, which are key triggers for GLP-1 release. The gut microbiome’s role in GLP-1 function represents an exciting frontier in metabolic health.

Lifestyle measures that complement natural approaches

Exercise emerges as a powerful GLP-1 enhancer, with resistance training taking priority. Studies show combining exercise with GLP-1 optimization reduces abdominal fat by 6.1% – more than double either approach alone. The “afterburn effect” from resistance training creates sustained metabolic benefits lasting up to 72 hours. Aim for 2-3 weekly sessions focusing on major muscle groups.

Sleep quality directly affects GLP-1 function, with research indicating that sleep fragmentation reduces GLP-1 concentrations and increases afternoon food intake. Prioritizing 7-9 hours of quality sleep supports the natural rhythms of GLP-1. Establish a consistent sleep schedule, limit screen time in the evening, and maintain a cool, dark sleeping environment. Morning light exposure within 30 minutes of waking helps regulate circadian rhythms that govern GLP-1 secretion.

Chronic stress undermines weight-loss efforts by elevating cortisol, which promotes abdominal fat storage and disrupts GLP-1 function. Daily stress management, whether through meditation, deep breathing, or exposure to nature, supports metabolic health. Even 10-20 minutes of mindfulness practice can measurably reduce cortisol levels.

The gut microbiome serves as a critical mediator of GLP-1 function. Beyond fermented foods, feeding beneficial bacteria requires diverse fiber sources; aim for 25-35 grams daily from various plant sources. Prebiotic foods, such as garlic, onions, asparagus, and Jerusalem artichokes, specifically nourish GLP-1-promoting bacteria. Think of your microbiome as a garden requiring consistent, varied nutrition.

Scientific evidence and realistic expectations

The research paints a clear picture: natural alternatives provide modest benefits compared to pharmaceutical options. While semaglutide achieves 15-22% weight loss, supplements such as berberine produce average losses of 2-5%. Other supplements exhibit even more minor effects, often indistinguishable from those of a placebo in rigorous trials.

Natural approaches require patience and consistency. While semaglutide users often see significant results within 3-6 months, natural GLP-1 enhancement typically shows effects after 8-12 weeks of sustained effort. The trade-off? Natural methods offer broader health benefits, including improved cardiovascular markers, better gut health, and enhanced insulin sensitivity, which extend beyond weight loss.

Practical implementation strategies

Success with natural GLP-1 enhancement requires systematic implementation. Start with one or two changes, building gradually over 8-12 weeks. A practical progression might look like:

• Weeks 1-2: Establish a consistent sleep schedule and add resistant starch to one meal daily. Begin tracking hunger and fullness cues.
• Weeks 3-4: Introduce time-restricted eating, starting with 12:12 and progressing to 14:10. Add a second serving of resistant starch or beta-glucan.
• Weeks 5-6: Implement meal sequencing (vegetables first) and slow eating practices. Consider adding berberine under medical supervision if appropriate.
• Weeks 7-8: Add resistance training twice weekly and daily fermented foods. Evaluate progress and adjust strategies based on results.

Monitor multiple markers beyond weight: energy levels, sleep quality, digestive health, and appetite control provide valuable feedback. Many report improved well-being before significant weight loss occurs.

Safety considerations and medical guidance

Natural doesn’t always mean safe. Berberine, despite being plant-derived, interacts with numerous medications, including diabetes drugs, blood thinners, and immunosuppressants. It can cause digestive upset, low blood pressure, and shouldn’t be used during pregnancy or by children.

The lack of regulation in the supplement industry poses additional risks. Unlike pharmaceuticals, supplements don’t require proof of safety or efficacy. Quality varies dramatically between brands, with contamination and mislabeling common problems. When choosing supplements, select products that have been third-party tested by reputable manufacturers.

Medical intervention becomes appropriate when natural approaches fail to achieve a 5% weight loss within 3-6 months, or when health conditions such as diabetes require pharmacologic management. For individuals with a BMI over 30 or over 27 with comorbidities, prescription GLP-1 agonists often represent the most effective option.

Conclusion

Natural alternatives to semaglutide offer modest yet meaningful benefits for weight management. The most effective approach combines multiple strategies, including resistant starch and beta-glucans for sustained GLP-1 stimulation, strategic protein intake, Mediterranean-style eating patterns, regular resistance training, quality sleep, and effective stress management. While these methods can’t match pharmaceutical potency, they provide sustainable, health-promoting benefits without the need for prescriptions or injections.

Success requires patience, consistency, and realistic expectations. Natural GLP-1 enhancement typically produces a 2-5% weight loss over several months, which is valuable for health but far from the results achieved with pharmaceuticals. For many, these approaches serve best as foundational healthy habits or as complements to medical treatment rather than replacements.

The future likely holds combined approaches: natural strategies providing the foundation for metabolic health, with pharmaceutical intervention when greater weight loss is medically necessary. By understanding both possibilities and limitations, individuals can make informed choices aligned with their health goals and circumstances. Remember, the most potent “natural GLP-1 agonist” remains a comprehensive healthy lifestyle. It’s less exciting than a miracle supplement, but proven effective for long-term wellness.

References

1. Ahlkvist L, Vikman J, Pacini G, Ahrén B. Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice. Regul Pept. 2012;178(1-3):29-35.
2. Asbaghi O, Ghanbari N, Shekari M, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2020;38:43-49.
3. Bajka BH, Pinto AM, Perez-Moral N, Saha S, Sheridan PO, van der Schoot A, Sheridan JI, Mayneris-Perxachs J, Ryden P, Ahn-Jarvis J, Berry SE, Ellis PR, Edwards CH. Enhanced secretion of satiety-promoting gut hormones in healthy humans after consumption of white bread enriched with cellular chickpea flour: A randomized crossover study. Am J Clin Nutr. 2023;117(3):477-489.
4. Benedict C, Barclay JL, Jauch-Chara K, et al. Acute sleep deprivation delays the glucagon-like peptide 1 peak response to breakfast in healthy men. Nutr Diabetes. 2013;3(7):e78.
5. Bodnaruc AM, Prud’homme D, Blanchet R, Giroux I. Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review. Nutr Metab (Lond). 2016;13:92.
6. Bourdon I, Olson B, Backus R, Richter BD, Davis PA, Schneeman BO. Beans, as a source of dietary fiber, increase cholecystokinin and apolipoprotein B48 response to test meals in men. J Nutr. 2001;131(5):1485-1490.
7. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015;11(10):577-91.
8. Canfora EE, Jocken JW, Blaak EE. Short-chain fatty acids in human gut and metabolic health. Beneficial Microbes. 2020;11(5):411-455.
9. Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, De Backer F, Neyrinck AM, Delzenne NM. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009;90(5):1236-1243.
10. Carnevale R, Loffredo L, Del Ben M, Angelico F, Nocella C, Petruccioli A, Bartimoccia S, Monticolo R, Cava E, Violi F. Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects. Nutr Diabetes. 2015;5:e172.
11. Carnevale R, Nocella C, Cammisotto V, Bartimoccia S, Castellani V, Loffredo L, Lorenzo AD, Reni L, Del Ben M, Violi F. Extra virgin olive oil improves post-prandial glycemic and lipid profile in patients with impaired fasting glucose. Clin Nutr. 2017;36(3):782-787.
12. Ceriello A, Esposito K, La Sala L, et al. The protective effect of the Mediterranean diet on endothelial resistance to GLP-1 in type 2 diabetes: a preliminary report. Cardiovasc Diabetol. 2014;13:140.
13. Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SEK, MacDougall K, Preston T, Tedford C, Finlayson GS, Blundell JE, Bell JD, Thomas EL, Mt-Isa S, Ashby D, Gibson GR, Kolida S, Dhillo WS, Bloom SR, Morley W, Clegg S, Frost G. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744-1754.
14. Christensen LW, Kuhre RE, Janus C, Svendsen B, Holst JJ. Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine. Physiol Rep. 2015;3(9):e12551.
15. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325-2340.
16. Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103.
17. Di Mauro A, Tuccinardi D, Watanabe M, et al. The Mediterranean diet increases glucagon-like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross-over trial. Diabetes Metab Res Rev. 2021;37(3):e3406.
18. Edfalk S, Steneberg P, Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes. 2008;57(9):2280-2287.
19. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013;110(22):9066-9071.
20. Feng X, Liu H, Li Z, Carughi A, Ge S. Acute effect of pistachio intake on postprandial glycemic and gut hormone responses in women with gestational diabetes or gestational impaired glucose tolerance: A randomized, controlled, crossover study. Front Nutr. 2019;6:186.
21. Freeland KR, Wilson C, Wolever TMS. Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr. 2010;103(1):82-90.
22. Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083-2091.
23. Hauge M, Vestmar MA, Husted AS, Ekberg JP, Wright MJ, Di Salvo J, Weinglass AB, Engelstoft MS, Madsen AN, Lückmann M, Miller MW, Trujillo ME, Frimurer TM, Holst B, Howard AD, Schwartz TW. GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo. Mol Metab. 2015;4(1):3-14.
24. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, Sugimoto Y, Miyazaki S, Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med. 2005;11(1):90-94.
25. Hsu CN, Lin YJ, Hou YC, Tain YL. High β-Glucan Barley Supplementation Improves Glucose Tolerance by Increasing GLP-1 Secretion in Diet-Induced Obesity Mice. Nutrients. 2021;13(2):527.
26. Ichimura A, Hara T, Hirasawa A. Regulation of energy homeostasis via GPR120. Front Endocrinol (Lausanne). 2014;5:111.
27. Jamshed H, Beyl RA, Della Manna DL, et al. Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults With Obesity: A Randomized Clinical Trial. JAMA Intern Med. 2022;182(9):953-962.
28. Kendall CWC, Josse AR, Esfahani A, Augustin LSA, Vidgen E, Bashyam B, Chiavaroli L, Jenkins AJ, Kris-Etherton PM, West SG, Jenkins DJA. Acute effects of pistachio consumption on glucose and insulin, satiety hormones and endothelial function in the metabolic syndrome. Eur J Clin Nutr. 2014;68(3):370-375.
29. Kuwata H, Iwasaki M, Shimizu S, et al. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial. Diabetologia. 2016;59(3):453-61.
30. Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci. 1995;40(5):1074-1082.
31. Lejeune MP, Westerterp KR, Adam TC, et al. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am J Clin Nutr. 2006;83(1):89-94.
32. Ma L, Hu L, Jin L, Wang J, Li Y, Wang L, Yang J, Luo Y, Ma X, Ye L. Rebalancing glucolipid metabolism and gut microbiome dysbiosis by nitrate-dependent alleviation of high-fat diet-induced obesity. BMJ Open Diabetes Res Care. 2020;8(1):e001255.
33. McRorie JW Jr, McKeown NM. Understanding the physics of functional fibers in the gastrointestinal tract: An evidence-based approach to resolving enduring misconceptions about insoluble and soluble fiber. J Acad Nutr Diet. 2017;117(2):251-264.
34. Nesti L, Mengozzi A, Tricò D. Impact of Nutrient Type and Sequence on Glucose Tolerance: Physiological Insights and Therapeutic Implications. Front Endocrinol (Lausanne). 2019;10:144.
35. Nilsson A, Johansson E, Ekström L, Björck I. Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a randomized cross-over study. PLoS ONE. 2013;8(4):e59985.
36. Nøhr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, Husted AS, Sichlau RM, Grunddal KV, Poulsen SS, Han S, Jones RM, Offermanns S, Schwartz TW. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology. 2013;154(10):3552-3564.
37. Pais R, Gribble FM, Reimann F. Stimulation of incretin secreting cells. Ther Adv Endocrinol Metab. 2016;7(1):24-42.
38. Panaro BL, Yusta B, Matthews D, Koehler JA, Song Y, Sandoval DA, Drucker DJ. Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion. Mol Metab. 2020;37:100990.
39. Paniagua JA, Gallego de la Sacristana A, Sánchez E, Romero I, Vidal-Puig A, Berral FJ, Escribano A, Moyano MJ, Pérez-Martínez P, López-Miranda J, Pérez-Jiménez F. A MUFA-rich diet improves postprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr. 2007;26(5):434-444.
40. Psichas A, Sleeth ML, Murphy KG, et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond). 2015;39(3):424-9.
41. Reimer RA, Thomson ABR, Rajotte RV, Basu TK, Ooraikul B, McBurney MI. Fermentable dietary fiber increases GLP-1 secretion and improves glucose homeostasis despite increased intestinal glucose transport capacity in healthy dogs. J Nutr. 1998;128(10):1786-1793.
42. Reutrakul S, Van Cauter E. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism. 2018;84:56-66.
43. Revheim I, Ballance S, Standal AF, Rieder A, Dierkes J, Buyken AE, Gilja OH, Hausken T, Rosendahl-Riise H. The acute effect of a β-glucan-enriched oat bread on gastric emptying, GLP-1 response, and postprandial glycaemia and insulinemia: a randomised crossover trial in healthy adults. Nutr Metab (Lond). 2024 Mar 18;21(1):13.
44. Rocca AS, LaGreca J, Kalitsky J, Brubaker PL. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1. Endocrinology. 2001;142(3):1148-1155.
45. Roopchand DE, Carmody RN, Kuhn P, Moskal K, Rojas-Silva P, Turnbaugh PJ, Raskin I. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes. 2015;64(8):2847-2858.
46. Sandsdal RM, Juhl CR, Jensen SBK, Lundgren JR, Janus C, Blond MB, Rosenkilde M, Bogh AF, Gliemann L, Jensen JB, Antoniades C, Stallknecht BM, Holst JJ, Madsbad S, Torekov SS. Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial. Cardiovasc Diabetol. 2023 Feb 25;22(1):41.
47. Shukla AP, Andono J, Touhamy SH, et al. Carbohydrate-last meal pattern lowers postprandial glucose and insulin excursions in type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000440.
48. Sodum N, Makki O, Engström M, Herzig KH, Raza GS. Nutrient combinations sensed by L-cell receptors potentiate GLP-1 secretion. Int J Mol Sci. 2024;25(2):1087.
49. Teong XT, Liu K, Vincent AD, Bensalem J, Liu B, Hattersley KJ, Zhao L, Feinle-Bisset C, Sargeant TJ, Wittert GA, Hutchison AT, Heilbronn LK. Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial. Nat Med. 2023 Apr;29(4):963-972.
50. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E, Cameron J, Grosse J, Reimann F, Gribble FM. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61(2):364-371.
51. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002.
52. Ye Y, Liu X, Wu N, et al. Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Pharmacol. 2021;12:653887.
53. Yoon HS, Cho CH, Yun MS, et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021;6(5):563-573.
54. Zhou J, Martin RJ, Raggio AM, Shen L, McCutcheon K, Keenan MJ. The importance of GLP-1 and PYY in resistant starch’s effect on body fat in mice. Mol Nutr Food Res. 2015 May;59(5):1000-3. doi: 10.1002/mnfr.201400904. Epub 2015 Mar 2.
55. Zhou J, Martin RJ, Tulley RT, et al. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab. 2008;295(5):E1160-6.